Health & Veritas Azita Emami: Educating Nurse-Leaders
Howie and Harlan are joined by Azita Emami, dean of the Yale School of Nursing, to discuss the school’s approach to training nurses who can have a seat at the table of healthcare decision-making. Harlan reports on his new study showing the low levels of evidence required for medical devices in the FDA’s Breakthrough Devices Program; Howie provides some good news about infectious diseases including malaria and HIV.
Links:
Breakthrough devices?
Harlan Krumholz: “FDA Authorization of Therapeutic Devices Under the Breakthrough Devices Program”
FDA: Breakthrough Devices Program
“Many medical devices deemed ‘breakthrough’ by FDA are backed by patchy evidence”
FDA Facts: Biomarkers and Surrogate Endpoints
Azita Emami
“Americans' Ratings of U.S. Professions Stay Historically Low”
“University of Washington selects Azita Emami as dean of School of Nursing”
“Azita Emami named new dean of School of Nursing”
“The Report of the Rockefeller Foundation on Nursing Education: A Review and Critique”
“DHEA as a Biomarker of Stress: A Systematic Review and Meta-Analysis”
Infectious diseases
WHO: World Malaria Report 2024
“Georgia certified malaria-free by WHO”
“Suriname certified malaria-free by WHO”
The Global Fund to Fight AIDS, Tuberculosis and Malaria
“Novartis wins approval for first malaria drug for newborns and babies”
“FDA Approves a Twice-Yearly Shot to Prevent HIV”
“U.S. measles cases hit highest level in 33 years, CDC reports”
Texas Department of State Health Services: Measles Outbreak
“The West Texas measles outbreak has started to slow for the first time since January”
Learn more about the MBA for Executives program at Yale SOM.